RichardMossMD

PubMed

• 147 citations
  Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.
  John A. Wagner, Anna H. Messner, Mary Lynn Moran, Richard Daifuku, Keisuke Kouyama
  The Laryngoscope. 1999-02-01
• 188 citations
  A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies.
  John A. Wagner, Ilynn B. Nepomuceno, Anna H. Messner, Mary Lynn Moran, Eric P. Batson
  Human Gene Therapy. 2002-07-20
• 178 citations
  A Phase I Study of Aerosolized Administration of tgAAVCF to Cystic Fibrosis Subjects with Mild Lung Disease
  Moira L. Aitken, Richard B. Moss, David A. Waltz, Mark Dovey, Mark R. Tonelli
  Human Gene Therapy. 2001-10-10

Journal Articles

• Prolonged corticosteroid therapy in cystic fibrosis.  
  Lewiston NJ, Moss RB, CF Club Abstr 22:131
• IgM and IgG rheumatoid factors in cystic fibrosis compared to rheumatic diseases of childhood and controls.  
  Moss RB, Hsu YP, Clin Res 30:96A
• Autoimmunity in cystic fibrosis: evidence against polyclonal B cell activation.  
  Moss RB, Hsu YP, J Allergy Clin Immunol 69:S112
• Circulating immune complexes decrease during corticosteroid therapy in cystic fibrosis.  
  Lewiston NJ, Moss RB, Pediatr Res 16:345A
• IgG4 antibodies to Pseudomonas aeruginosa in cystic fibrosis.  
  Moss RB, Hsu YP, Leahy M, Halpern G, CF Club Abstr 23:13
• IgE and IgG antibodies to casein in suspected cow's milk allergy.  
  Leong RE, Moss RB, Blessing J, Cheung NKV, Cheung I, Lewiston NJ, Ann Allergy 50:352
• Humoral immune response to inhaled and parenteral allergens: role of IgG4 antibody in clinical protection.  
  Moss RB, Hsu YP, J Allergy Clin Immunol 73:138
• A quantitative immunoenzymatic assay for allergenspecific IgE antibodies. Comparison with three other in vitro assays.  
  Moss RB, Hsu YP, Kwasnicki M, Reid MJ, Clin Res 32:41A
• Towards a quantitative enzyme-linked immunosorbent assay for specific IgE.  
  Kwasnicki JM, Moss RB, Cheung NKV, Reid MJ, J Allergy Clin Immunol 73:152
• Once a day theophylline in asthmatic adolescents.  
  Blessing J, Leong RE, Machtinger S, Lewiston N, Moss RB, Clin Res 32:61A
• Once daily theophylline (Uniphyl) for treatment of bronchospasm in patients with cystic fibrosis and asthma  
  Blessing J, Leong RE, Machtinger S, Lewiston N, Moss RB, Rubinstein S, Hindi R, Ann Allergy 52:235
• A quantitative immunoenzymatic assay for grass pollen-specific IgG antibodies.  
  Moss RB, Hsu YP, J Allergy Clin Immunol 75:175
• Normal suppressor T cell function in hospitalized patients with cystic fibrosis.  
  J Allergy Clin Immunol 75:175, Clin Res 33:82A
• In vitro screening for allergic antibodies in young children.  
  Hindi R, Hsu YP, Moss RB, Lewiston NJ, Ann Allergy 54:360
• Alveolar macrophage phagocytosis of Pseudomonas aeruginosa opsonized by normal, cystic fibrosis, and murine monoclonal antibodies.  
  Moss RB, Hsu YP, Am Rev Respir Dis 131:A22
• Opsonization of Pseudomonas aeruginosa by human polyclonal, murine monoclonal, and cystic fibrosis-derived human monoclonal antibodies.  
  Moss RB, Hsu YP, Larrick JW, CF Club Abstr 26:23
• Effect of nocturnal feeding via percutaneous endoscopic gastrostomy on nutrition and growth in cystic fibrosis.  
  Adams L, Moss RB, Hindi R, Rubinstein S, Sullivan M, Lewiston N, CF Club Abstr 26:83
• Production of type-specific human monoclonal antibodies to Pseudomonas aeruginosa.  
  Larrick JW, Moss RB, Hart S, Hsu YP, Dyer B, CF Club Abstr 26:133
• Allotype, isotype, and immune response in cystic fibrosis.  
  Moss RB, Hsu YP, Lewiston NJ, De Lange G, J Allergy Clin Immunol 79:143
• Dissecting the atopic immune response to grass pollen.  
  Moss RB, Hsu YP, Reid MJ, J Allergy Clin Immunol 79:215
• Impaired natural IgG2 antibody response to polysaccharide antigens and decreased Km(1)-A2m(2) allotypes in cystic fibrosis.  
  Moss RB, Hsu YP, Lewiston NJ, De Lange G, Pediatr Res 21:330A
• Defective antibody-mediated opsonization of Pseudomonas aeruginosa in cystic fibrosis: an isotype-dependent defect?  
  Moss RB, Eichler I, J Allergy Clin Immunol 81:298
• A primate model of chronic Pseudomonas bronchopneumonia.  
  Moss RB, Kurland G, Ayin S, Lewiston NJ, Cheung ATW, Am Rev Respir Dis 137:318
• Role of antigen and isotype in defective opsonization of Pseudomonas aeruginosa in CF.  
  Moss R, Joris L, Hsu Y, Eichler I, Pediatr Pulmonol S2:124
• Are IgG4 antibodies to lipopolysaccharide antigens of Pseudomonas aeruginosa opsonophagocytic blocking factors in cystic fibrosis?  
  Moss RB, Joris L, Hsu YP, Van Wye J, Eichler I, American Association for the Advancement of Science, Annual Meeting Abstracts, p. 59
• Join now to see all

Books/Book Chapters

• Bronchial Asthma. Principles of Diagnosis and Treatment. 
  Chapter: Differential diagnosis of asthma in children 
  Page 141 - 169Moss RBEditors: Gershwin ME and Halpern GM.The Humana Press Inc., Totowa NJEdition 3rd,
• Johns Hopkins Advanced Studies in Medicine 10. 
  Chapter: Cystic fibrosis: pathophysiology and therapeutic Targets 
  Page 9 - 13. Moss RBEditors: Ahead of the Curve – Emerging CF Therapies.
• Pediatr Pulmonol 44: Suppl 32. 
  Chapter: Practicalities of ABPA diagnosis and treatment 
  Page 201 - 202Moss RB
• Aspergillus fumigatus and Aspergillosis. 
  Chapter: Allergic bronchopulmonary aspergillosis, Chpt 26 
  Page 333 - 350Moss RBEditors: Latge JP, Steinbach WJ.American Society of Microbiology Press, Washington DC
• Commentaries on Chronic Airway Infection vol 2. 
  Chapter: Chest imaging in cystic fibrosis 
  Page 2 - 8Robinson T, Moss REdition no 3,
• Current Allergy and Asthma Reports. 
  Chapter: Management of allergic aspergillosis 
  Page 433 - 439Moss RB
• Current Fungal Infection Reports. 
  Chapter: Management of allergic aspergillosis 
  Page 87 - 93Moss RB
• Pediatric Respiratory Medicine. 
  Chapter: Allergic bronchopulmonary aspergillosis, Chpt 46 
  Page 681 - 691Moss RBEditors: Taussig LM, Landau LI, LeSouef PN, Martinez FD, Morgan WJ, Sly PD.Elsevier, Inc., TorontoEdition 2nd,
• Commentaries on Chronic Airway Infection vol 2. 
  Chapter: Fungal infection in chronic airway infection 
  Page 2 - 8Moss RBEdition no 1,
• Johns Hopkins Advanced Studies in Medicine 7. 
  Chapter: Clinical management and monitoring lung function 
  Page 440 - 450Moss RBEditors: Aggressive Treatment Strategies in the Fight Against Cystic Fibrosis (with JP Clancy).
• Mold Allergy, Biology and Pathogenesis 2005. 
  Chapter: Aspergillus Antigens and Immunodiagnosis of Allergic Bronchopulmonary Aspergillosis 
  Page 137 - 146Kurup VP, Knutsen AP, Moss RBEditors: Kurup VS.Research Signpost, Trivandrum, Kerala India
• Mold Allergy, Biology and Pathogenesis 2005. 
  Chapter: Fungal Allergy in Cystic Fibrosis 
  Page 93 - 104Moss RBEditors: Kurup VS.Research Signpost, Trivandrum, Kerala India
• Cystic Fibrosis: Treatment Practice Guidelines Pocket Guide. 
  Bloch EA, Germana J, Konstan M, Kuhn R, Llewellyn A, Moss R, Nickerson B, Rinker K, Sufian BS, VanDevanter D, Wagener JProfessional Resources in Management Education, Inc.
• Cystic Fibrosis: From Theory to Practice. 
  Schidlow D, Butler S, Eigen H, Johnson C, Konstan M, Marshall B, McColley S, Morgan W, Moss R, Rosenstein B, Smaldone GC, Watrous M, Wagener JGardiner-Caldwell SynerMed/MCP Hahnemann University
• Diseases of the Sinuses: A Comprehensive Textbook of Diagnosis and Treatment. 
  Chapter: Sinus disease in cystic fibrosis 
  Page 357 - 365Light M, Moss RB, Davidson TMEditors: Gershwin EM, & Incaudo GA.Humana Press, Inc., Totowa NJ
• Textbook of Cystic Fibrosis. 
  Chapter: Immunology of cystic fibrosis: immunity, immunodeficiency, and hypersensitivity 
  Page 109 - 151Moss RBEditors: Lloyd-Still JD.Wright-PSG Publishing Inc., Boston
• Sinusitis-- Pathophysiology and Treatment. 
  Chapter: Sinusitis and polyposis in cystic fibrosis 
  Page 247 - 281Moss RBEditors: Druce HM.Marcel Dekker, New York
• Pediatric Respiratory Diseases: Diagnosis and Treatment. 
  Chapter: Immunopathogenesis of cystic fibrosis lung disease 
  Page 674 - 687Moss RBEditors: Hillman B.W.B. Saunders, Philadelphia
• Pediatric Respiratory Diseases: Diagnosis and Treatment. 
  Chapter: Pulmonary defenses 
  Page 36 - 46Moss RBEditors: Hillman B.W.B. Saunders, Philadelphia
• Nelson Self-Assessment in Pediatrics. 
  Chapter: Pediatric Respiratory Medicine: Gastroesophageal reflux-associated lung disease 
  Moss RBEditors: Prober CG, Behrman RE.CME Supplement Test No. ZN9212
• Cystic Fibrosis. Infection, Immunopathology, and Host Response. 
  Chapter: Drug allergy in cystic fibrosis 
  Page 211 - 229Moss RBEditors: Moss RB.Humana Press, Clifton NJ
• Cystic Fibrosis. Infection, Immunopathology, and Host Response. 
  Page 1 - 151Moss RBThe Humana Press Inc., Totowa NJ
• Basic and Clinical Aspects of IgG Subclasses. Monographs in Allergy. 
  Chapter: IgG subclasses in respiratory disorders: cystic fibrosis 
  Page 202 - 209Moss RBEditors: Shakib F.SW Karger, BaselEdition vol.,
• Human Hybridomas: Diagnostic and Therapeutic Applications. 
  Chapter: Generation and characterization of human monoclonal anti-Pseudomonas aeruginosa antibodies 
  Page 65 - 80Larrick JW, Hart SM, Lippman D, Glembourtt M, Hsu YP, Moss RBEditors: Strelkauskas A.Marcel Dekker, Inc., New York
• Human Hybridomas and Monoclonal Antibodies. 
  Chapter: In vitro expansion of human B cells for the production of human monoclonal antibodies 
  Page 149 - 165Larrick JW, Dyer BJ, Senyk G, Hart SM, Moss RB, Lippman D, Jahnsen MC, Wang J, Weintraub H, Raubitschek AAEditors: Engleman EG, Foung SKH, Larrick JW, Raubitschek AA.Plenum Press, NY
• Join now to see all

Abstracts/Posters

• Treatment of Early Pseudomonoas Aeruginosa Infection – When and How.
  Moss RB, Dannemiller Memorial Educational Foundation CME Faculty, Los Angeles CA
• Atopy in Asthma: Making the Pieces Fit in Clinical Practice
  Moss RB, with Richard J.Martin MD, Postgraduate Institute of Medicine/Respiratory & Allergic Disease Foundation CME Teleconference
• Childhood asthma.
  Moss RB, Pediatric Grand Rounds, Community Hospital of Monterey Peninsula,Monterey CA
• Phase 3 study of denufosol for cystic fibrosis.
  Moss RB, American Thoracic Society annual meeting, San Diego CA
• Childhood asthma.
  Moss RB, East Bay Asthma Coalition Educational Forum, Oakland CA
• Lymphocytes in Cystic Fibrosis: Actors or Voyeurs?
  Moss RB, Physiology Grand Round, Johns Hopkins School of Medicine, Baltimore MD
• Pediatric Fungal Lung Disease.
  Moss RB, Grand Rounds, Children’s Hospital of Central California, Madera CA
• Cystic Fibrosis – Adult Issues.
  Moss RB, Department of Medicine, UCSF – Fresno campus, Fresno CA
• Glutathione and N-acetylcysteine in Cystic Fibrosis.
  Moss RB, Mountain West CF Consortium, Denver CO
• Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis.
  Moss RB, Mountain West CF Consortium, Denver CO
• Lymphoctes in Cystic Fibrosis. Workshop on Targeting Inflammation in Cystic Fibrosis.
  Moss RB, Novartis Institute for Biomedical Research, Horsham UK
• Asthma Mini-Seminar. Popular Pediatric Clinical Topics – 2007.
  Moss RB, Lucile Packard Children’s Hospital CME Course, Mauna Lani Bay HI
• Inflammation Overview.
  Moss RB, GlaxoSmithKline CF2110399 Trial Investigators’ Meeting, Chicago IL
• Treatment of Early Pseudomonoas Aeruginosa Infection – When and How.
  Moss RB, Dannemiller Memorial Educational Foundation CME Faculty, Salt Lake City UT
• Treatment of Early Pseudomonoas Aeruginosa Infection – When and How.
  Moss RB, Dannemiller Memorial Educational Foundation CME Faculty, Albany NY
• The New Horizon of Cystic Fibrosis in the Emerging Adult Population: An Interactive CME Experience.
  Moss RB, Medical Education Resources, Inc CME Chair and Faulty., Presentations in New York NY and Los Angeles CA
• Master Clinicians Present Optimizing Care Across a Lifetime: A Cystic Fibrosis TownMeeting™.
  Moss RB, Postgraduate Institute of Medicine CME Faculty. Six Webcasts
• Fungal Infection in Cystic Fibrosis.
  Moss RB, Physician’s Grand Rounds Discussant, North American Cystic Fibrosis Conference, Anaheim CA
• Practical Asthma – Achieving Success in a Variable Disease.
  Moss RB, with Gary Rachelefsky MD, Palo Alto CA
• Inhaled Antibiotics for Airway Infection.
  Moss RB, Jilu Hospital, Shandong University, Jinan, China
• Asthma, Recent Ideas and Treatment Advances.
  Moss RB, State University of New York Upstate Medical Center, Pediatric Grand Rounds, Syracuse NY
• Update on Cystic Fibrosis Clinical Research.
  Moss RB, American Thoracic Society American Thoracic Society 2006 International Conference, San Diego CA
• Crtique of Trials in ABPA and Fungal Allergy.
  Moss RB, Crtique of Trials in ABPA and Fungal Allergy., Athens Greece
• Allergen Sensitization in Allergic Bronchopulmonary Aspergillosis, Plenary Session on Allergy.
  Moss RB, 18th Congress of the International Society for Human and Animal Mycology, Berlin
• Modulatory effects of Aspergillus colonization and ABPA on blood and sputum eosinophils and neutrophils in CF.
  Gernez Y, Everson C, Dunn CE, Fernandez-Becker N, Gudiputi L, Davies ZA, Herzenberg LA, Tirouvanziam R, Moss RB, European CF Conference
• Join now to see all

Lectures

• Current Status of Early Treatment for CF Lung Infection. 
  Montreal Children's Hospital-McGill University, Montreal Canada
• Cystic Fibrosis Quality Care for Quality Outcomes. 
  Children’s Hospital, Columbus
• CF Lung Disease: Is There a Threshold for Intervention? 
  University of Wisconson, Madison WI - 11/10/2005; West Palm Beach FL
• Improving Practices to Preserve Pulmonary Function, A Focus on Pseudomonas aeruginosa. 
  Fresno CA - 5/23/2008; St. Louis MO - 7/22/2009; Baltimore MD
• Cystic Fibrosis: Are Clinical Signs and Symptoms a Starting Point or a Midpoint in Lung Disease? 
  Burlingame CA - 9/10/2008; Santa Ana CA
• Preserving Lung Function in Cystic Fibrosis; Allergic Bronchopulmonary Aspergillosis in Cystic Fibosis. 
  University of Calgary
• Childhood Asthma: Control and Beyond. 
  Abu Dhabi - 10/1/2009; Al Ain
• Cystic Fibrosis Lung Disease: Rethinking the At-Risk Patient. 
  Albany NY - 11/12/2009; Children’s Hospital Los Angeles, CA
• Join now to see all

Other

• BioMedNet Biofeedback Interview. 
  Moss RB, HMS Beagle vol 63
  http://news.bmn.com/hmsbeagle/63/notes/biofeed
• Cystic fibrosis: new insights and treatments. 
  Moss RB, Hospital Practice 36:25-37
  http://www.hosppract.com/issues/2001/01/moss.htm
• Gene therapy for cystic fibrosis: the rise and fall of a viral vector. 
  Moss RB, US Respiratory Disease, 40-41
  http://www.touchbriefings.com/download.cfm?fileID=9161
• Allergic bronchopulmonary aspergillosis. 
  Moss RB, eCystic Fibrosis Review
  http://www.eCysticFibrosisReview.org
• Join now to see all